Catherine Paul Selected Research

Intraperitoneal Injections

4/2013

Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine Paul Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 09/2008
4	Breast Neoplasms (Breast Cancer) 06/2023 - 06/2011
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2014
3	Inflammation (Inflammations) 08/2020 - 07/2008
3	Neoplasm Metastasis (Metastasis) 05/2019 - 01/2017
2	Infections 11/2023 - 01/2017
2	Carcinogenesis 01/2022 - 01/2017
1	COVID-19 11/2023
1	Triple Negative Breast Neoplasms 06/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2015
1	Long QT Syndrome 02/2015
1	Peritoneal Neoplasms 04/2013
1	Melanoma (Melanoma, Malignant) 09/2010
1	Septic Shock (Toxic Shock Syndrome) 01/2010
1	Sepsis (Septicemia) 01/2010
1	Tachycardia (Tachyarrhythmias) 01/2010
1	Leukopenia 01/2010
1	Hypothermia 01/2010
1	Tachypnea 01/2010
1	Leukocytosis (Pleocytosis) 01/2010
1	Endotoxemia 07/2008

Drug/Important Bio-Agent (IBA)

7	Lipid AIBA 06/2018 - 01/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2020 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2017
3	GoldIBA 01/2022 - 06/2015
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2016 - 04/2013
2	Lipoproteins (Lipoprotein)IBA 10/2022 - 07/2008
2	Protein Kinase InhibitorsIBA 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2014
2	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2022 - 03/2015
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 11/2014
2	Death Domain ReceptorsIBA 01/2017 - 06/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2016 - 04/2013
2	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2015 - 06/2011
2	LipidsIBA 04/2013 - 06/2011
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Oxygen (Dioxygen)IBA 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2023
1	azaBDPBA compoundIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Coloring Agents (Dyes)IBA 01/2023
1	Niclosamide FDA Link 01/2023
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2023
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022
1	LDL Receptors (LDL Receptor)IBA 10/2022
1	Leucine (L-Leucine)FDA Link 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	phosphine (phosphane)IBA 01/2022
1	Chemokine CCL20IBA 01/2022
1	Chemokine CXCL10IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	AntidiarrhealsIBA 01/2021
1	Valine (L-Valine)FDA Link 08/2020
1	Calcium-Sensing ReceptorsIBA 08/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2019
1	ChemokinesIBA 06/2018
1	EnzymesIBA 06/2018
1	Granzymes (Granzyme)IBA 06/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Hepatitis C virus E1 proteinIBA 01/2017
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Superoxides (Superoxide)IBA 05/2016
1	Peroxynitrous Acid (Peroxynitrite)IBA 05/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2016
1	InterferonsIBA 05/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	SaltsIBA 06/2015
1	Adenosine Triphosphate (ATP)IBA 03/2015
1	Purinergic Receptors (Receptors, Purine)IBA 03/2015
1	NitratesIBA 03/2015
1	Domperidone (Domperidon)IBA 02/2015
1	PlatinumIBA 11/2014
1	LipopolysaccharidesIBA 04/2013
1	Fas Ligand Protein (Fas Ligand)IBA 06/2011
1	Biotin (Vitamin H)FDA Link 06/2011
1	Phospholipid Transfer ProteinsIBA 07/2008

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2010
4	Immunotherapy 01/2022 - 11/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
2	Precision Medicine 08/2021 - 01/2017
2	Injections 11/2014 - 01/2010
1	Cytoreduction Surgical Procedures 01/2023
1	Neoadjuvant Therapy 01/2018
1	Folfox protocol 01/2018
1	Intraperitoneal Injections 04/2013